Wednesday, July 8, 2026

biotech · Post Traumatic Stress Disorder · Prosthetic Joint Infection · ADPT

Adaptive Biotechnologies

Adaptive Biotechnologies is a biotech organization headquartered in Seattle, USA. It trades on NYSE under ticker ADPT. Primary therapeutic focus areas include Post Traumatic Stress Disorder, Prosthetic Joint Infection, O

1165 Eastlake Ave E, Seattle, Washington 98109, US HQ
2009 Founded
659 Employees
Public company Type
ADPT · NYSE Ticker
Company details
Status
Public
HQ
1165 Eastlake Ave E, Seattle, Washington 98109, US
Founded
2009
Employees
659
Programs
19
Drugs
23
Patents
12
Clinical program

Radiation

Unknown · other · Rectal Cancer

Radiation for Rectal Cancer is a Unknown program (other) at Adaptive Biotechnologies Corp with 1 ClinicalTrials.gov record(s).

Internal code RECTAL MRI SIM 25409

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Adaptive Biotechnologies Corp
Phase
Unknown
Modality
other
Indication
Rectal Cancer
Status
completed
Trials
1

Clinical trials